Published in Nucleic Acids Res on March 25, 1990
Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev (1999) 7.76
Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res (1990) 2.93
Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun (1997) 2.42
Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev (1993) 2.19
Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect Immun (1998) 1.63
A genomic sample sequence of the entomopathogenic bacterium Photorhabdus luminescens W14: potential implications for virulence. Appl Environ Microbiol (2000) 1.36
Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect Immun (1997) 1.34
Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B. J Clin Microbiol (1991) 1.20
Macrofragment localization of the toxin A and toxin B genes of Clostridium difficile. Clin Diagn Lab Immunol (1996) 0.75
Effects of anti-inflammatory drugs on fever and neutrophilia induced by Clostridium difficile toxin B. Mediators Inflamm (1996) 0.75
Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays. J Clin Microbiol (1992) 0.75
Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Cloning and characterization of overlapping DNA fragments of the toxin A gene of clostridium difficile. J Gen Microbiol (1989) 1.44
Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature (1995) 6.08
A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol (1998) 4.79
The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem (1995) 3.02
Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene (1996) 2.87
Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem (1997) 2.25
Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem (1994) 2.09
Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. FEMS Microbiol Lett (1997) 1.88
Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun (2001) 1.85
A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins. J Biol Chem (1999) 1.58
The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. J Clin Invest (1995) 1.51
Genetic rearrangements in the pathogenicity locus of Clostridium difficile strain 8864--implications for transcription, expression and enzymatic activity of toxins A and B. Mol Gen Genet (1998) 1.49
Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J Biol Chem (1996) 1.39
GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: direct activation of Cdc42. J Biol Chem (2001) 1.27
Variant toxin B and a functional toxin A produced by Clostridium difficile C34. FEMS Microbiol Lett (2001) 1.22
Cellular UDP-glucose deficiency caused by a single point mutation in the UDP-glucose pyrophosphorylase gene. J Biol Chem (1997) 1.17
A chimeric ribozyme in clostridium difficile combines features of group I introns and insertion elements. Mol Microbiol (2000) 1.16
Inhibition of Fc epsilon-RI-mediated activation of rat basophilic leukemia cells by Clostridium difficile toxin B (monoglucosyltransferase) J Biol Chem (1996) 1.13
Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill (2008) 1.12
Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin. Infect Immun (1995) 1.11
A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin. Toxicon (1991) 1.10
The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality. FEMS Microbiol Lett (1997) 1.05
UDP-glucose deficiency in a mutant cell line protects against glucosyltransferase toxins from Clostridium difficile and Clostridium sordellii. J Biol Chem (1996) 1.04
Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function. Am J Physiol (1997) 0.99
Inhibition of receptor signaling to phospholipase D by Clostridium difficile toxin B. Role of Rho proteins. J Biol Chem (1996) 0.98
Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile. Mol Gen Genet (1995) 0.93
A role for Rho in receptor- and G protein-stimulated phospholipase C. Reduction in phosphatidylinositol 4,5-bisphosphate by Clostridium difficile toxin B. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.91
Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II. Br J Pharmacol (2000) 0.90
Characterisation of cryptic plasmids in clinical isolates of Bacteroides fragilis. J Med Microbiol (1985) 0.89
Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ral GTPases. J Biol Chem (1998) 0.89
Morphological changes of cultured endothelial cells after microinjection of toxins that act on the cytoskeleton. Infect Immun (1992) 0.89
Demonstration that the group II intron from the Clostridial Conjugative transposon Tn5397 undergoes splicing In vivo. J Bacteriol (2001) 0.87
UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C. J Biol Chem (1998) 0.85
Clostridium difficile toxins A and B inhibit human immune response in vitro. Infect Immun (1988) 0.85
Activation of astroglial phospholipase D activity by phorbol ester involves ARF and Rho proteins. Biochim Biophys Acta (2000) 0.82
Delineation of the catalytic domain of Clostridium difficile toxin B-10463 to an enzymatically active N-terminal 467 amino acid fragment. FEMS Microbiol Lett (1997) 0.81
Probing the action of Clostridium difficile toxin B in Xenopus laevis oocytes. J Cell Sci (1994) 0.81
The actin-based motility of intracellular Listeria monocytogenes is not controlled by small GTP-binding proteins of the Rho- and Ras-subfamilies. FEMS Microbiol Lett (1999) 0.80
Rho protein inhibition blocks protein kinase C translocation and activation. Biochem Biophys Res Commun (1998) 0.80
Small GTP-binding proteins of the Rho- and Ras-subfamilies are not involved in the actin rearrangements induced by attaching and effacing Escherichia coli. FEMS Microbiol Lett (1998) 0.80
Impact of amino acids 22-27 of Rho-subfamily GTPases on glucosylation by the large clostridial cytotoxins TcsL-1522, TcdB-1470 and TcdB-8864. Eur J Biochem (1999) 0.80
Regulation of phospholipase D activity in synaptosomes permeabilized with Staphylococcus aureus alpha-toxin. FEBS Lett (1998) 0.79
[Emergence of clostridium difficile ribotype 027 in Germany: epidemiological and clinical characteristics]. Z Gastroenterol (2010) 0.77
Purification and evaluation of large clostridial cytotoxins that inhibit small GTPases of Rho and Ras subfamilies. Methods Enzymol (2000) 0.76
[Nosocomial epidemiology and transmission of Clostridium difficile infection]. Dtsch Med Wochenschr (2001) 0.75
Isolation and purification of plasmids from Bacteroides fragilis using rubidium trichloroacetate density gradient centrifugation. Mol Gen Genet (1983) 0.75